Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11311
Peer-review started: June 28, 2021
First decision: July 26, 2021
Revised: July 27, 2021
Accepted: November 5, 2021
Article in press: November 5, 2021
Published online: December 26, 2021
Processing time: 178 Days and 6.3 Hours
Acute otitis media (AOM) is a common disease that is more prevalent in children. Most studies concerning AOM-associated sudden sensorineural hearing loss are case reports and retrospective in nature, hence the etiology of AOM-associated sudden hearing loss has not been fully established.
To analyze audiological characteristics of AOM-associated sudden hearing loss and evaluate efficacy of combined tympanostomy tube placement (TTP) and intratympanic methylprednisolone.
Eight adult patients who were diagnosed with AOM-associated sudden hearing loss and ineffectively treated by conventional medical therapy were enrolled in this study. Basic data were collected, and pure tone audiometry was performed to assess the audiological characteristics. Combination therapy with TTP and intratympanic methylprednisolone injection was given to the patients.
Mixed or sensorineural hearing loss was observed at high frequencies (2–4 kHz). All the cases in this study were cured after TTP and intratympanic methylprednisolone. After treatment, the average hearing threshold at affected frequencies was significantly lower than those in the pretreatment group (P < 0.05) and was similar to that in the healthy ears (P > 0.05).
AOM rarely induces sudden sensorineural hearing loss. Combination therapy with TTP and intratympanic methylprednisolone injection may be effective after failure of conventional medical treatment.
Core Tip: Acute otitis media (AOM)-associated sudden sensorineural hearing loss is a rare otological condition and the mechanism and treatment methods have not been defined. This study described the audiological features of the patients with AOM-associated sudden hearing loss and evaluated the clinical efficacy of tympanostomy tube placement and intratympanic methylprednisolone injection after failure of conventional medical therapy.